With offices worldwide and capabilities in more than 40 countries, Pharm-Olam has the resources to conduct clinical trials across the world — from Phase I studies with unique patient populations to large multi-national Phase III trials. This advantage allows us to go further than other CROs to find difficult to recruit patients.

Our global decentralization model uses our own local staff to perform all regulatory work, study set-up, and monitoring for our trials — helping sponsors start up faster and reducing pass-through costs throughout the duration of the study.